Pfizer says 'game changer' pills could save thousands of lives
Pfizer's forthcoming COVID-19 treatment could be authorized for emergency use in the United States by the end of this year or early next year, pending the Food and Drug Administration's regulatory timeline, Pfizer CEO Albert Bourla told ABC News.
The pharmaceutical giant announced Tuesday that it has submitted promising new data to the FDA, including lab experiments showing its oral antiviral medicine, Paxlovid, will likely work against the omicron variant. And in updated clinical trial data, Pfizer found the treatment reduces the risk of being hospitalized or dying by 89% when taken within three days of being diagnosed with COVID-19, and 88% when taken within five days of being diagnosed among high-risk, unvaccinated patients.
![](https://s.abcnews.com/images/Health/pfizer-pill-gty-ps-211213_1639431363042_hpMain.jpg)
"It is a game changer," Bourla told ABC News. "But at the same time, I want to emphasize that no one should use the existence of the pill as an excuse to avoid vaccination."
Bourla said the medicine could save thousands of lives.
"We did some calculations how many deaths or hospitalizations can be avoided based on the current U.S. mortality rates and the current U.S. hospitalization rates," he said. "On the back-of-the-envelope calculation, we estimate that 100,000 people if they take the pill, we will avoid 6,000 hospitalizations and 1,200 deaths approximately."
-ABC News' Sony Salzman